dalteparin has been researched along with Muscle Weakness in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Muscle Weakness: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wolf, G | 1 |
| Stahl, RA | 1 |
| Patel, S | 1 |
| Sanborn, D | 1 |
| Issa, M | 1 |
2 other studies available for dalteparin and Muscle Weakness
| Article | Year |
|---|---|
A woman with increasing weakness of the legs and irregular heartbeat who took her husband's medication.
Topics: Aged; Anticoagulants; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Male; Muscle Weakne | 2002 |
57-Year-Old Woman With Weakness and Word-Finding Difficulties.
Topics: Adenocarcinoma, Clear Cell; Antibodies, Antiphospholipid; Aspirin; Biomarkers, Tumor; Cerebral Infar | 2021 |